Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.
Jing SunQulu ZhengAlfred J AnzaloneAlison G AbrahamAmy L OlexYifan ZhangJomol MathewNasia SafdarMelissa A HaendelDorry SegevJessica Yasmine IslamJasvinder A SinghRoslyn B MannonChristopher G ChuteRena C PatelGregory D KirkPublished in: Open forum infectious diseases (2024)
Booster vaccines remain effective against severe COVID-19 BTI throughout the Delta- and Omicron-predominant periods, regardless of patients' immune status.
Keyphrases
- coronavirus disease
- end stage renal disease
- early onset
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- sars cov
- systematic review
- prognostic factors
- oxidative stress
- peritoneal dialysis
- quality improvement
- electronic health record
- patient reported outcomes
- machine learning
- artificial intelligence